206 related articles for article (PubMed ID: 28536806)
41. Survival outcomes of patients with colorectal liver metastases following hepatic resection or ablation in the era of effective chemotherapy.
Nikfarjam M; Shereef S; Kimchi ET; Gusani NJ; Jiang Y; Avella DM; Mahraj RP; Staveley-O'Carroll KF
Ann Surg Oncol; 2009 Jul; 16(7):1860-7. PubMed ID: 19037703
[TBL] [Abstract][Full Text] [Related]
42. Predicting early intrahepatic recurrence after curative resection of colorectal liver metastases with molecular markers.
Narita M; Oussoultzoglou E; Chenard MP; Fuchshuber P; Yamamoto T; Addeo P; Jaeck D; Bachellier P
World J Surg; 2015 May; 39(5):1167-76. PubMed ID: 25561185
[TBL] [Abstract][Full Text] [Related]
43. Perioperative chemotherapy for resectable colorectal liver metastases: Analysis from the Colorectal Operative Liver Metastases International Collaborative (COLOMIC).
Gawdi R; Valenzuela CD; Moaven O; Stauffer JA; Del Piccolo NR; Cheung T; Corvera CU; Wisneski AD; Cha C; Russell G; Zarandi N; Dourado J; Shen P
J Surg Oncol; 2022 Aug; 126(2):339-347. PubMed ID: 35429409
[TBL] [Abstract][Full Text] [Related]
44. Effect of Time to Surgery of Colorectal Liver Metastases on Survival.
Chen EY; Mayo SC; Sutton T; Kearney MR; Kardosh A; Vaccaro GM; Billingsley KG; Lopez CD
J Gastrointest Cancer; 2021 Mar; 52(1):169-176. PubMed ID: 32086781
[TBL] [Abstract][Full Text] [Related]
45. The clinical relevance of the Fong and the Nordlinger scores in the era of effective neoadjuvant chemotherapy for colorectal liver metastasis.
Schreckenbach T; Malkomes P; Bechstein WO; Woeste G; Schnitzbauer AA; Ulrich F
Surg Today; 2015 Dec; 45(12):1527-34. PubMed ID: 25563588
[TBL] [Abstract][Full Text] [Related]
46. Microscopic biliary and perineural invasion and clinical outcome after neoadjuvant bevacizumab-based chemotherapy and liver resection in patients with colorectal liver metastases.
Stift J; Graf A; Schwarz C; Tamandl D; Starlinger P; Herac M; Beer A; Wrba F; Bodingbauer M; Kaczirek K; Stremitzer S
Eur J Surg Oncol; 2018 Jan; 44(1):139-147. PubMed ID: 29203074
[TBL] [Abstract][Full Text] [Related]
47. T cells but not NK cells are associated with a favourable outcome for resected colorectal liver metastases.
Pugh SA; Harrison RJ; Primrose JN; Khakoo SI
BMC Cancer; 2014 Mar; 14():180. PubMed ID: 24625075
[TBL] [Abstract][Full Text] [Related]
48. Intrahepatic CD69
Bruni E; Cimino MM; Donadon M; Carriero R; Terzoli S; Piazza R; Ravens S; Prinz I; Cazzetta V; Marzano P; Kunderfranco P; Peano C; Soldani C; Franceschini B; Colombo FS; Garlanda C; Mantovani A; Torzilli G; Mikulak J; Mavilio D
J Immunother Cancer; 2022 Jul; 10(7):. PubMed ID: 35863820
[TBL] [Abstract][Full Text] [Related]
49. The Prognosis of Patients with Liver Metastases from Colorectal Cancer still Depends on Anatomical Presentation more than on Treatments.
Gobbi PG; Rossi S; Comelli M; Ravetta V; Rosa LL; Brugnatelli S; Corbella F; Delfanti S; Abumalouh I; Dionigi P
Curr Cancer Drug Targets; 2015; 15(6):511-8. PubMed ID: 26282549
[TBL] [Abstract][Full Text] [Related]
50. Outcome of microscopic incomplete resection (R1) of colorectal liver metastases in the era of neoadjuvant chemotherapy.
Ayez N; Lalmahomed ZS; Eggermont AM; Ijzermans JN; de Jonge J; van Montfort K; Verhoef C
Ann Surg Oncol; 2012 May; 19(5):1618-27. PubMed ID: 22006375
[TBL] [Abstract][Full Text] [Related]
51. A multicentre study of capecitabine, oxaliplatin plus bevacizumab as perioperative treatment of patients with poor-risk colorectal liver-only metastases not selected for upfront resection.
Wong R; Cunningham D; Barbachano Y; Saffery C; Valle J; Hickish T; Mudan S; Brown G; Khan A; Wotherspoon A; Strimpakos AS; Thomas J; Compton S; Chua YJ; Chau I
Ann Oncol; 2011 Sep; 22(9):2042-2048. PubMed ID: 21285134
[TBL] [Abstract][Full Text] [Related]
52. Adjuvant systemic chemotherapy after putative curative resection of colorectal liver and lung metastases.
Brandi G; Derenzini E; Falcone A; Masi G; Loupakis F; Pietrabissa A; Pinna AD; Ercolani G; Pantaleo MA; Di Girolamo S; Grazi GL; de Rosa F; Biasco G
Clin Colorectal Cancer; 2013 Sep; 12(3):188-94. PubMed ID: 23773458
[TBL] [Abstract][Full Text] [Related]
53. Sinusoidal obstruction syndrome impairs long-term outcome of colorectal liver metastases treated with resection after neoadjuvant chemotherapy.
Tamandl D; Klinger M; Eipeldauer S; Herberger B; Kaczirek K; Gruenberger B; Gruenberger T
Ann Surg Oncol; 2011 Feb; 18(2):421-30. PubMed ID: 20844968
[TBL] [Abstract][Full Text] [Related]
54. Radiological Morphology of Colorectal Liver Metastases after Preoperative Chemotherapy Predicts Tumor Viability and Postoperative Outcomes.
Nishioka Y; Shindoh J; Yoshioka R; Gonoi W; Abe H; Okura N; Yoshida S; Oba M; Hashimoto M; Watanabe G; Hasegawa K; Kokudo N
J Gastrointest Surg; 2015 Sep; 19(9):1653-61. PubMed ID: 25917536
[TBL] [Abstract][Full Text] [Related]
55. Metabolic response to preoperative chemotherapy predicts prognosis for patients undergoing surgical resection of colorectal cancer metastatic to the liver.
Lau LF; Williams DS; Lee ST; Scott AM; Christophi C; Muralidharan V
Ann Surg Oncol; 2014 Jul; 21(7):2420-8. PubMed ID: 24595797
[TBL] [Abstract][Full Text] [Related]
56. Impact of Neoadjuvant Chemotherapy on the Postoperative Outcomes of Patients Undergoing Liver Resection for Colorectal Liver Metastases: A Population-Based Propensity-Matched Analysis.
Wiseman JT; Guzman-Pruneda F; Xourafas D; Chun YS; Ejaz A; Tsung A; Pawlik TM; Cloyd JM
J Am Coll Surg; 2019 Jul; 229(1):69-77.e2. PubMed ID: 30905856
[TBL] [Abstract][Full Text] [Related]
57. Survival outcomes of liver metastasectomy in colorectal cancer cases: a single-center analysis in Turkey.
Cokmert S; Ellidokuz H; Demir L; Fuzun M; Astarcioglu I; Aslan D; Yilmaz U; Oztop I
Asian Pac J Cancer Prev; 2014; 15(13):5195-200. PubMed ID: 25040974
[TBL] [Abstract][Full Text] [Related]
58. Trends in the multimodality treatment of resectable colorectal liver metastases: an underutilized strategy.
Parikh AA; Ni S; Koyama T; Pawlik TM; Penson D
J Gastrointest Surg; 2013 Nov; 17(11):1938-46. PubMed ID: 24018590
[TBL] [Abstract][Full Text] [Related]
59. Repeat Hepatectomy for Recurrent Colorectal Liver Metastases: Is it Worth the Challenge?
Ali MA; Di Sandro S; Lauterio A; Concone G; Mangoni I; Ferla F; Rotiroti V; Cusumano C; Giacomoni A; De Carlis L
J Gastrointest Surg; 2015 Dec; 19(12):2192-8. PubMed ID: 26361773
[TBL] [Abstract][Full Text] [Related]
60. Liver Resection for Non-colorectal Non-neuroendocrine Metastases: Where Do We Stand Today Compared to Colorectal Cancer?
Schiergens TS; Lüning J; Renz BW; Thomas M; Pratschke S; Feng H; Lee SM; Engel J; Rentsch M; Guba M; Werner J; Thasler WE
J Gastrointest Surg; 2016 Jun; 20(6):1163-72. PubMed ID: 26921025
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
